Bangladesh Class A Devices: Declaration of Conformity Route

1. Key takeaways

Class A devices in Bangladesh follow the Declaration of Conformity route. §4.5 of the DGDA Medical Device Registration Guidelines establishes three things. Conformity assessment for Class A is, in principle, the manufacturer’s own responsibility. The manufacturer does not need to obtain a manufacturing licence from the DGDA. The manufacturer must nonetheless notify the DGDA of conformity by means of a declaration of conformity. Practice adds three further points that shape the commercial case: no government fee is charged for a Class A application, the certificate carries no expiry date, and the approval period runs at roughly one month. Together these features produce the peculiar economics of this class, in which almost all effort is concentrated before filing and almost none afterwards.

• The route is a declaration, not an assessment performed by the authority.
• The manufacturing licence is waived; the notification duty is not.
• No fee and no expiry date make Class A structurally different from Class B, C and D.
• A one-month approval figure applies to the review itself, not to preparation of the attestation chain.
• Document requirements remain substantial, including embassy attestation of the country of origin CFS.

2. Legal basis

The guideline text supplies the obligation. The document list and the fee, timing and validity points come from registration practice and are labelled accordingly, because they are not written into §4.5 itself.

3. Expert insights

Insight one: no manufacturing licence does not mean no registration. Chinese-language material frequently compresses §4.5 into the claim that Class A is exempt from registration, and that reading is wrong. What the provision waives is the manufacturing licence. What it imposes at the same time is a notification obligation, under which the manufacturer must actively submit a declaration of conformity to the DGDA. One obligation is removed and another is added, so the net obligation does not fall to zero. A manufacturer that treats the absence of a licence requirement as the absence of any filing requirement simply fails to appear in the record, which becomes visible the moment an import consignment needs to be moved. The notification is what creates the record against which import documentation is later checked, and it is the manufacturer’s own evidence that it has done what §4.5 asks.

Insight two: not one link in the attestation chain can be dropped. In practice a Class A application still requires a country of origin CFS attested by the Bangladesh embassy. Bangladesh is not a party to the 1961 Hague Convention, so Apostille is unavailable, a point treated in detail in the twenty-fourth article of this series. The proposition that low risk means light formality therefore holds in Bangladesh only for fee and timeline. It does not hold for documentary preparation, which is close to the standard applied at higher classes. Planning a Class A file as though it were a formality is the most common budgeting error at this class, and it usually surfaces as a courier problem rather than a legal one.

Insight three: the absence of an expiry date is the main practical value of Class A. Certificates for Class B, C and D are valid for five years and must be renewed. A Class A certificate has no expiry date. For a low-risk device with a long product life cycle and a stable model range, that single feature removes the whole cost of renewal from the lifetime of the product, including the documentation refresh and the attestation work that renewal normally entails. The advantage compounds over time, because a registered Class A product never re-enters the queue for a renewal file while a higher-class holder does.

4. Practical recommendations

• Draft the declaration of conformity as a formal legal document rather than a formatted certificate. It should state the standards applied, which may be ISO or IEC standards or a manufacturer-defined validation standard in line with §4.2 of the guidelines, together with the product list and the manufacturer name and address.
• Have the declaration signed by an authorised signatory whose authority is documented, so that the document stands on its own if it is queried later. A board resolution or an equivalent instrument held on file is normally sufficient evidence of that authority.
• Schedule the embassy attestation chain and the original document requirement of the final review stage into the project plan at the outset. A shorter review does not shorten attestation.
• Confirm the class in writing before preparing the declaration, since the declaration route is only available where Class A is settled and recorded.
• Record in the plan that no renewal step applies, so that resources are not reserved for a renewal that will never be required.
• Keep the attested CFS and the signed declaration in one place, so that both can be produced together when the final stage calls for originals.

5. Verification checklist

• □ Product confirmed as falling within Class A
• □ Declaration of conformity prepared, including standards applied and the product list
• □ Bangladesh embassy attestation obtained for the country of origin CFS
• □ Confirmed that no DGDA manufacturing licence application is required
• □ Recorded that the Class A certificate has no expiry date, with no renewal step in the schedule

Regulatory information verified as of 27 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across South Asia, including Bangladesh. Our team prepares dossiers to DGDA expectations, manages submissions and deficiency responses, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com